SONN icon

Sonnet BioTherapeutics

12 hedge funds and large institutions have $1.86M invested in Sonnet BioTherapeutics in 2015 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 4 closing their positions.

Holders
12
Holders Change
+1
Holders Change %
+9.09%
% of All Funds
0.32%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
5
Reduced
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Millennium Management
1
Millennium Management
New York
$531K 222,222
TDC
2
Thompson Davis & Co
Virginia
$501K 209,605 +2,218 +1%
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$260K 108,667 +108,667 New
BIT
4
BlackRock Institutional Trust
California
$162K 67,705 +18,639 +38%
Bank of America
5
Bank of America
North Carolina
$121K 50,385 +28,957 +135%
CDH
6
Charles D. Hyman
$106K 44,444
EVC
7
Eidelman Virant Capital
Missouri
$72K 30,000 +30,000 New
Citadel Advisors
8
Citadel Advisors
Florida
$34K 14,200 +14,200 New
SWP
9
Stratos Wealth Partners
Ohio
$34K 14,400 +14,400 New
CL
10
CSS LLC
Illinois
$27K 11,364 +11,364 New
UBS Group
11
UBS Group
Switzerland
$6K 2,429 +429 +21%
Morgan Stanley
12
Morgan Stanley
New York
$4K 1,750 +1,738 +14,483%
VKH
13
Virtu KCG Holdings
New York
-42,626 Closed
WA
14
WFG Advisors
Texas
-23,332 Closed
Neuberger Berman Group
15
Neuberger Berman Group
New York
-13,000 Closed
TRCT
16
Tower Research Capital (TRC)
New York
-380 Closed